6 Migraine Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting Migraine Studies in Birmingham

NCT04649242Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....

Birmingham, ALPHASE32,100 participantsPfizer

View Study Details

NCT07645924Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with placebo, in the acute treatment of migraine....

Birmingham, ALPHASE31,800 participantsKallyope Inc.

View Study Details

NCT06625060Recruiting

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and s...

Birmingham, ALPHASE2641 participantsIpsen

View Study Details

NCT06417775Recruiting

Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

A migraine is a moderate to severe headache typically on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, o...

Birmingham, ALPHASE3496 participantsAbbVie

View Study Details

NCT06602479Recruiting

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine....

Birmingham, ALPHASE2488 participantsAbbVie

View Study Details

NCT04748601Recruiting

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

A Phase 4 study to evaluate Qudexy XR for the prevention of migraine in children 6 to 11 years of age....

Birmingham, ALPHASE4132 participantsUpsher-Smith Laboratories

View Study Details

About Migraine Clinical Trials in Birmingham

Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.

There are currently 6 migraine clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 5,657 participants. Research is being sponsored by Pfizer, Kallyope Inc., Ipsen and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Migraine Clinical Trials in Birmingham — FAQ

Are there migraine clinical trials in Birmingham?

Yes, there are 6 migraine clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What migraine treatments are being tested?

The 6 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.

Data updated July 17, 2026 from ClinicalTrials.gov